Please login to the form below

Not currently logged in
Email:
Password:

TNF

This page shows the latest TNF news and features for those working in and with pharma, biotech and healthcare.

GSK sells eczema and psoriasis drug to Dermavant for £250m

GSK sells eczema and psoriasis drug to Dermavant for £250m

also the emergence of biosimilars for older TNF inhibitor blockbusters pegging back prices.

Latest news

More from news
Approximately 1 fully matching, plus 187 partially matching documents found.

Latest Intelligence

  • Customer experience rules the digital age Customer experience rules the digital age

    Take the area of anti-TNFs and their biosimilar competitors. Competition here is becoming fierce and is being led more and more by customers’overall experiences, including service-led patient support

  • Deal Watch December 2016 Deal Watch December 2016

    Not disclosed. Bispecific antibody technology. Exicure. Purdue. $790m. Not disclosed. Spherical Nucleic Acid technology and a topical anti-TNF product.

  • Opening up innovation Opening up innovation

    In much the same way that the last decade saw the anti-TNF treatments for autoimmune conditions become a 'pipeline in a product', Paul-Peter says that with Benlysta GSK has “

  • Cost containment and the German market Cost containment and the German market

    The main sales drivers are biopharmaceutical medicines like the monoclonal antibody adalimumab, TNF-alpha inhibitor etanercept as well as the oncologic drugs imatinib and enzalutamide.

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Among these are Avaxia Biologics, which is developing an anti-tumour necrosis factor (TNF) antibody for inflammatory bowel disease and UK-based VH Squared, which has an early-stage programme ongoing

More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics